|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CTNNA1-EGR1 (FusionGDB2 ID:20254) |
Fusion Gene Summary for CTNNA1-EGR1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CTNNA1-EGR1 | Fusion gene ID: 20254 | Hgene | Tgene | Gene symbol | CTNNA1 | EGR1 | Gene ID | 1495 | 1958 |
| Gene name | catenin alpha 1 | early growth response 1 | |
| Synonyms | CAP102|MDPT2 | AT225|G0S30|KROX-24|NGFI-A|TIS8|ZIF-268|ZNF225 | |
| Cytomap | 5q31.2 | 5q31.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | catenin alpha-1alpha-E-catenincatenin (cadherin-associated protein), alpha 1, 102kDaepididymis secretory sperm binding proteinrenal carcinoma antigen NY-REN-13 | early growth response protein 1EGR-1nerve growth factor-induced protein Atranscription factor ETR103transcription factor Zif268zinc finger protein 225zinc finger protein Krox-24 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | P18146 | |
| Ensembl transtripts involved in fusion gene | ENST00000355078, ENST00000302763, ENST00000518825, ENST00000520400, ENST00000540387, | ENST00000239938, | |
| Fusion gene scores | * DoF score | 25 X 19 X 12=5700 | 7 X 10 X 3=210 |
| # samples | 34 | 11 | |
| ** MAII score | log2(34/5700*10)=-4.06735526780176 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/210*10)=-0.932885804141463 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CTNNA1 [Title/Abstract] AND EGR1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CTNNA1(138163407)-EGR1(137802446), # samples:2 CTNNA1(138163407)-EGR1(137802445), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | CTNNA1-EGR1 seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF. CTNNA1-EGR1 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CTNNA1 | GO:0071681 | cellular response to indole-3-methanol | 10868478 |
| Tgene | EGR1 | GO:0006366 | transcription by RNA polymerase II | 19057511 |
| Tgene | EGR1 | GO:0033233 | regulation of protein sumoylation | 19057511 |
| Tgene | EGR1 | GO:0045893 | positive regulation of transcription, DNA-templated | 12560508 |
| Tgene | EGR1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 19057511 |
| Tgene | EGR1 | GO:0098759 | cellular response to interleukin-8 | 20363028 |
| Tgene | EGR1 | GO:1902895 | positive regulation of pri-miRNA transcription by RNA polymerase II | 19307576 |
| Fusion gene breakpoints across CTNNA1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across EGR1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | ESCA | TCGA-L5-A4OQ-01A | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802446 | + |
| ChimerDB4 | ESCA | TCGA-L5-A4OQ | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + |
| ChimerDB4 | ESCA | TCGA-L5-A4OQ | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + |
| ChimerDB4 | ESCA | TCGA-L5-A4OQ-01A | CTNNA1 | chr5 | 138163407 | - | EGR1 | chr5 | 137802446 | + |
Top |
Fusion Gene ORF analysis for CTNNA1-EGR1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000355078 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802446 | + |
| Frame-shift | ENST00000302763 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802446 | + |
| Frame-shift | ENST00000518825 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802446 | + |
| intron-3CDS | ENST00000520400 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802446 | + |
| intron-3CDS | ENST00000540387 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802446 | + |
| Frame-shift | ENST00000355078 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + |
| Frame-shift | ENST00000302763 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + |
| Frame-shift | ENST00000518825 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + |
| intron-3CDS | ENST00000520400 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + |
| intron-3CDS | ENST00000540387 | ENST00000239938 | CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CTNNA1-EGR1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + | 2.60E-05 | 0.999974 |
| CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + | 2.60E-05 | 0.999974 |
| CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + | 2.60E-05 | 0.999974 |
| CTNNA1 | chr5 | 138163407 | + | EGR1 | chr5 | 137802445 | + | 2.60E-05 | 0.999974 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CTNNA1-EGR1 |
| Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | EGR1 |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Transcriptional regulator (PubMed:20121949). Recognizes and binds to the DNA sequence 5'-GCG(T/G)GGGCG-3'(EGR-site) in the promoter region of target genes (By similarity). Binds double-stranded target DNA, irrespective of the cytosine methylation status (PubMed:25258363, PubMed:25999311). Regulates the transcription of numerous target genes, and thereby plays an important role in regulating the response to growth factors, DNA damage, and ischemia. Plays a role in the regulation of cell survival, proliferation and cell death. Activates expression of p53/TP53 and TGFB1, and thereby helps prevent tumor formation. Required for normal progress through mitosis and normal proliferation of hepatocytes after partial hepatectomy. Mediates responses to ischemia and hypoxia; regulates the expression of proteins such as IL1B and CXCL2 that are involved in inflammatory processes and development of tissue damage after ischemia. Regulates biosynthesis of luteinizing hormone (LHB) in the pituitary (By similarity). Regulates the amplitude of the expression rhythms of clock genes: ARNTL/BMAL1, PER2 and NR1D1 in the liver via the activation of PER1 (clock repressor) transcription. Regulates the rhythmic expression of core-clock gene ARNTL/BMAL1 in the suprachiasmatic nucleus (SCN) (By similarity). {ECO:0000250|UniProtKB:P08046, ECO:0000269|PubMed:20121949, ECO:0000269|PubMed:25258363, ECO:0000269|PubMed:25999311}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CTNNA1-EGR1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for CTNNA1-EGR1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CTNNA1-EGR1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CTNNA1-EGR1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CTNNA1 | C1708349 | Hereditary Diffuse Gastric Cancer | 3 | ORPHANET |
| Hgene | CTNNA1 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
| Hgene | CTNNA1 | C0026998 | Acute Myeloid Leukemia, M1 | 1 | CTD_human |
| Hgene | CTNNA1 | C0238198 | Gastrointestinal Stromal Tumors | 1 | CTD_human |
| Hgene | CTNNA1 | C1837029 | Macular Dystrophy, Butterfly-Shaped Pigmentary, 2 | 1 | CTD_human;UNIPROT |
| Hgene | CTNNA1 | C1868569 | Patterned dystrophy of retinal pigment epithelium | 1 | CTD_human |
| Hgene | CTNNA1 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 1 | CTD_human |
| Hgene | CTNNA1 | C2713368 | Hematopoetic Myelodysplasia | 1 | CTD_human |
| Hgene | CTNNA1 | C3179349 | Gastrointestinal Stromal Sarcoma | 1 | CTD_human |
| Hgene | CTNNA1 | C3463824 | MYELODYSPLASTIC SYNDROME | 1 | CTD_human |
| Hgene | CTNNA1 | C4511237 | Butterfly-shaped pigmentary macular dystrophy | 1 | ORPHANET |
| Tgene | EGR1 | C0009171 | Cocaine Abuse | 3 | CTD_human |
| Tgene | EGR1 | C0236736 | Cocaine-Related Disorders | 3 | CTD_human |
| Tgene | EGR1 | C0600427 | Cocaine Dependence | 3 | CTD_human |
| Tgene | EGR1 | C0008372 | Intrahepatic Cholestasis | 2 | CTD_human |
| Tgene | EGR1 | C0003129 | Anoxemia | 1 | CTD_human |
| Tgene | EGR1 | C0003130 | Anoxia | 1 | CTD_human |
| Tgene | EGR1 | C0004364 | Autoimmune Diseases | 1 | CTD_human |
| Tgene | EGR1 | C0007786 | Brain Ischemia | 1 | CTD_human |
| Tgene | EGR1 | C0008311 | Cholangitis | 1 | CTD_human |
| Tgene | EGR1 | C0008370 | Cholestasis | 1 | CTD_human |
| Tgene | EGR1 | C0020295 | Hydronephrosis | 1 | CTD_human |
| Tgene | EGR1 | C0021368 | Inflammation | 1 | CTD_human |
| Tgene | EGR1 | C0022116 | Ischemia | 1 | CTD_human |
| Tgene | EGR1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
| Tgene | EGR1 | C0025500 | Mesothelioma | 1 | CTD_human |
| Tgene | EGR1 | C0032285 | Pneumonia | 1 | CTD_human |
| Tgene | EGR1 | C0032300 | Lobar Pneumonia | 1 | CTD_human |
| Tgene | EGR1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Tgene | EGR1 | C0035126 | Reperfusion Injury | 1 | CTD_human |
| Tgene | EGR1 | C0087031 | Juvenile-Onset Still Disease | 1 | CTD_human |
| Tgene | EGR1 | C0242184 | Hypoxia | 1 | CTD_human |
| Tgene | EGR1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
| Tgene | EGR1 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| Tgene | EGR1 | C0700292 | Hypoxemia | 1 | CTD_human |
| Tgene | EGR1 | C0887898 | Experimental Lung Inflammation | 1 | CTD_human |
| Tgene | EGR1 | C0917798 | Cerebral Ischemia | 1 | CTD_human |
| Tgene | EGR1 | C2239176 | Liver carcinoma | 1 | CTD_human |
| Tgene | EGR1 | C3495559 | Juvenile arthritis | 1 | CTD_human |
| Tgene | EGR1 | C3714636 | Pneumonitis | 1 | CTD_human |
| Tgene | EGR1 | C3714758 | Juvenile psoriatic arthritis | 1 | CTD_human |
| Tgene | EGR1 | C4552091 | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1 | CTD_human |
| Tgene | EGR1 | C4704862 | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies